Jason Haddock serves as Executive at ARRAY BIOPHARMA INC, where they oversee executive responsibilities. Since joining the company, Jason Haddock has executed 16 insider transactions totaling $2.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 16, 2023 involved exercising options for 8,750 shares valued at $0.
Jason Haddock currently holds 8,750 shares of ARRAY BIOPHARMA INC (ARRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Haddock has been a net seller of ARRY stock. They have purchased $0 and sold $2.9M worth of shares.
Jason Haddock's most recent insider trade was on Feb 16, 2023, when they sold 8,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 30, 2019 | ARRY | $1.4M | Disposition | 30,059 | $48.00 | Discretionary |
| Feb 7, 2019 | ARRY | $320.4K | Option Exercise | 85,000 | $3.77 | Discretionary |
| Feb 7, 2019 | ARRY | $1.9M | Sale | 85,000 | $22.05 | Discretionary |
| Feb 6, 2019 | ARRY | $234.2K | Sale | 11,712 | $20.00 | Discretionary |
| Dec 16, 2018 | ARRY | $80.0K | Payment | 5,009 | $15.97 | Discretionary |
| Dec 16, 2018 | ARRY | $0 | Option Exercise | 11,387 | $N/A | Discretionary |
| Aug 15, 2018 | ARRY | $278.4K | Sale | 20,000 | $13.92 | Discretionary |
| Jul 30, 2018 | ARRY | $194.2K | Option Exercise | 51,525 | $3.77 | Discretionary |
| Jul 30, 2018 | ARRY | $371.8K | Sale | 25,000 | $14.87 | Discretionary |
| Jan 16, 2018 | ARRY | $52.9K | Option Exercise | 14,025 | $3.77 | Discretionary |
| Jan 16, 2018 | ARRY | $103.0K | Sale | 7,500 | $13.73 | Discretionary |
| Dec 16, 2017 | ARRY | $22.3K | Payment | 2,044 | $10.92 | Discretionary |
| Dec 16, 2017 | ARRY | $0 | Option Exercise | 4,387 | $N/A | Discretionary |
| Aug 14, 2017 | ARRY | $75.4K | Option Exercise | 20,000 | $3.77 | Discretionary |